HEATR7B2 inhibitors represent a chemical class targeting the HEATR7B2 protein, a member of the HEAT repeat-containing family. HEAT repeats are structural motifs composed of two alpha-helices linked by a short loop, often involved in intracellular transport, signal transduction, and protein-protein interactions. HEATR7B2 itself plays a significant role in cellular processes like protein folding and stabilization, contributing to the assembly and maturation of multi-protein complexes. Inhibitors targeting HEATR7B2 disrupt its function, leading to alterations in protein homeostasis and perturbations in the dynamics of cellular machinery. The specificity of these inhibitors for the HEATR7B2 protein depends on their ability to interfere with the characteristic folding motifs or binding interfaces that facilitate the protein's role in complex formation and function.
Structurally, HEATR7B2 inhibitors are designed to interact with distinct regions of the HEAT repeat motifs, blocking their ability to mediate essential interactions within the cell. These inhibitors can be small molecules or peptides, meticulously engineered to recognize and bind to key residues involved in HEATR7B2's functional sites. The modulation of HEATR7B2 activity by inhibitors can affect various downstream cellular pathways, particularly those related to the regulation of molecular chaperones and co-factors. This precise interference underscores the importance of HEATR7B2 in maintaining cellular equilibrium, and the use of these inhibitors provides an essential tool for understanding the fundamental biochemical and structural roles of this protein in various biological contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that blocks ATP binding sites, decreasing HEATR7B2 kinase activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Binds to FKBP12 and inhibits mTOR, a kinase that indirectly regulates HEATR7B2 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, reducing AKT phosphorylation and downstream signaling affecting HEATR7B2. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, altering ERK pathway signaling which is implicated in HEATR7B2 regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, modulating the stress response pathway in which HEATR7B2 is a component. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK, leading to reduced cytoskeletal reorganization that HEATR7B2 is involved with. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MEK inhibitor, altering the MAPK/ERK pathway and consequently HEATR7B2 signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits the JNK signaling pathway, thereby modulating the cellular processes linked to HEATR7B2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent PI3K inhibitor that disrupts AKT activation, impacting HEATR7B2 downstream effects. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that can affect protein degradation pathways involving HEATR7B2. | ||||||